Literature DB >> 31116156

Validation protocols for blood pressure measuring devices: the impact of the European Society of Hypertension International Protocol and the development of a Universal Standard.

Eoin O'Brien1, George Stergiou2, Paolo Palatini3, Roland Asmar4, John P Ioannidis5,6,7,8, Anastasios Kollias2, Peter Lacy9, Richard J McManus10, Martin G Myers11,12, Andrew Shennan13, Jiguang Wang14, Gianfranco Parati15,16.   

Abstract

In the last three decades protocols for the validation of blood pressure measuring devices have been developed by the US Association for the Advancement of Medical Instrumentation, the British Hypertension Society, the German Hypertension League, the European Society of Hypertension Working Group on blood pressure Monitoring and the International Organization for Standardization. The European Society of Hypertension International Protocol required much smaller sample size than the other protocols, aiming to reduce the time, resources and cost of validation studies and thereby increase the number of validated devices. Given its specifications, the European Society of Hypertension International Protocol was adequate for 'high- and low-accuracy' devices, yet assessment of 'moderate accuracy' devices had high uncertainty with resultant high rate of device failure. Thus, devices validated using the European Society of Hypertension International Protocol should be considered to be as accurate as those validated with the previous Association for the Advancement of Medical Instrumentation or British Hypertension Society protocols. However, the European Society of Hypertension International Protocol did not allow subgroup evaluation (arm sizes, special populations, etc). The mission of the European Society of Hypertension International Protocol to promote the concept of validation has been well achieved, as almost double studies have been published using it than all the other protocols together. However, the maintenance of different validation protocols is confusing and therefore experts from the Association for the Advancement of Medical Instrumentation, European Society of Hypertension International Protocol and International Organization for Standardization have now developed the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) as the recommended 21st-century procedure for worldwide application. The European Society of Hypertension Working Group has published a practical guide for using the Universal Standard. It is in the interests of all scientific bodies to propagate the Universal Standard and ensure its wide implementation.

Entities:  

Mesh:

Year:  2019        PMID: 31116156     DOI: 10.1097/MBP.0000000000000391

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  4 in total

1.  Association of Psychosocial Symptoms, Blood Pressure, and Menopausal Status in African-American Women.

Authors:  Carolyn H Still; Sadia Tahir; Hossein N Yarandi; Mona Hassan; Faye A Gary
Journal:  West J Nurs Res       Date:  2020-06-26       Impact factor: 1.967

2.  The Hypertension Canada blood pressure device recommendation listing: Empowering use of clinically validated devices in Canada.

Authors:  Raj Padwal; Angelique Berg; Mark Gelfer; Karen Tran; Jennifer Ringrose; Marcel Ruzicka; Swapnil Hiremath
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-27       Impact factor: 3.738

3.  Validation of Omron HBP-1100-E Professional Blood Pressure Measuring Device According to the American Association for the Advancement of Medical Instrumentation Protocol: The PERSIAN Guilan Cohort Study (PGCS).

Authors:  Farahnaz Joukar; Sara Yeganeh; Mohammadreza Naghipour; Soheil Hassanipour; Hossein-Ali Nikbakht; Fariborz Mansour-Ghanaei
Journal:  Med Devices (Auckl)       Date:  2020-09-03

4.  STRIDE BP international initiative for accurate blood pressure measurement: Systematic review of published validation studies of blood pressure measuring devices.

Authors:  George S Stergiou; Eoin O'Brien; Martin Myers; Paolo Palatini; Gianfranco Parati; Anastasios Kollias; Dimos Birmpas; Konstantinos Kyriakoulis; Ioanna Bountzona; Emelina Stambolliu; Ioannis Anagnostopoulos; Nikos Karpettas; Ariadni Menti
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-26       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.